Studies that investigated the toxicity of anti-EGFR MoAbs mainly focused on the common adverse events, such as skin rash [39], hematologic toxicity [40], and specific electrolyte disturbance like hypomagnesemia [41]. Here, EGFR is linked to Hypomagnesemia.